Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amplio Spine is a founder-led, commercial-stage medical device company focused on advancing innovative solutions for spinal stabilization and supplemental fusion. Headquartered in Boca Raton, Florida, the company's lead platform is KeyLift, an FDA-cleared expandable interlaminar stabilization system designed for posterior non-pedicle supplemental fixation at a single level in the non-cervical spine (T1–S1). KeyLift is commercialized in two configurations, KeyLiftXL and KeyLiftXS, offering eight cleared sizes to accommodate varying patient anatomy. Amplio Spine is dedicated to supporting appropriate clinical pathways and physician education to improve outcomes for patients suffering from lumbar spinal stenosis, degenerative disc disease, and other spinal conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amplio Spine.